Innovation at the core.
A small blood test.
A big impact.
The OncoDiscover® CTC Test is India's first indigenously developed, patented in-vitro diagnostic test to get MD-9 CDSCO approval in India.
This test is a highly specific and sensitive test that can detect, capture and enumerate Circulating Tumor Cells in very low volume of blood. Circulating Tumor Cells are a telltale signature of cancer metastasis.
Leading institutions use
the OncoDiscover® CTC
OncoDiscover® CTC test is being widely accepted by the oncology fraternity and is used for monitoring and effective therapy decisions.
A proven track record
15000+
Patients Served
500+
Doctors Trust Us
100+
Publications
OncoDiscover® CTC
Applicable across 15+ cancer types: Bladder, Breast, Cervical, Colorectal, Esophageal, Gallbladder, GI, Head & Neck, Lung, Ovarian, Pancreatic, Prostate, Kidney, Testicular & Thyroid.
OncoDiscover® CTC + PD-L1
Applicable across 15+ cancer types: Bladder, Breast, Cervical, Colorectal, Esophageal, Gallbladder, GI, Head & Neck, Lung, Ovarian, Pancreatic, Prostate, Kidney, Testicular & Thyroid.
OncoDiscover® CTC + HER-2
Applicable to cancers of the Breast, Colorectal, Gallbladder, Gastrointestinal, Head & Neck, Lung, Prostate and Thyroid.
OncoDiscover® CTC + EGFR
Detect and monitor CTCs and EGFR expression to gain insights into tumor biology, disease progression, and treatment response in NSCLC and lung cancer.
OncoDiscover® CTC + AR-V7
Characterize AR-V7–positive CTCs in real time to uncover molecular signals associated with treatment resistance and better understand the evolving biology of advanced prostate cancer.
OncoDiscover® EMT CTC
This test monitors CTCs expressing epithelial (EpCAM, CK) and mesenchymal (vimentin) markers, associated with increased mobility, invasion, metastasis, and therapy resistance.
OncoDiscover® CTC Test empowers oncologists to make better treatment decisions for improved outcomes
See what renowned medical oncologist -Dr Nirmal Raut has to say →
Requires just 10ml of blood
The OncoDiscover® CTC Test requires only 10 ml of the patient’s blood sample.
Can be done frequently
The OncoDiscover® CTC Test can be done at regular intervals for continuous monitoring and arriving at therapy decisions.
No exposure to radiation
The test is conducted on patient’s blood sample at our diagnostic laboratory. Patients don’t have to go through any physically painful and emotionally stressful tests that use radiations.
Convenient. No fasting.
Our registered phlebotomists can collect the blood samples from patient’s home. There are no restrictions with regards to fasting or medication for the blood sample.
The OncoDiscover® Liquid Biopsy Test detects and characterizes minimal cellular residual disease (MCRD) with PD-L1, HER-2, EGFR, AR-V7 and EMT CTCs
The OncoDiscover® Circulating Tumor Cells Test can detect CTCs originating from Epithelial Cancers (Carcinomas). Some major Carcinomas are:
- Head & Neck,
- Breast, Lung,
- Colorectal,
- Prostate,
- Cervical,
- Gall Bladder, etc.These constitute more than 70% of all the Cancers of the world.
However, the OncoDiscover® Circulating Tumor Cells Test does not detect Sarcoma, Melanoma, Lymphoma and Leukemia.
Please contact us to see if you qualify for this test.
-
Patients diagnosed with epithelial cancers: The OncoDiscover® CTC Test can be used to understand the spread of cancer in patients diagnosed with epithelial cancers.
-
Patients undergoing therapy: The OncoDiscover® CTC Test can be used to monitor CTC levels in patients undergoing therapy to understand the effectiveness of the therapy.
-
Patients in remission: The OncoDiscover® CTC Test can be used to monitor CC levels in patients to detect cancer relapse at the earliest stage.
-
Patients with suspected but undetectable epithelial cancers: In many cases, doctors may suspect a cancer due to symptoms or preliminary testing but may not be able to conclusively diagnose a cancer. The OncoDiscover® CTC Test can be used to detect presence of cancer cells in the blood as conclusive evidence of metastasis
-
The OncoDiscover® CTC Test is a DCGI approved simple and safe blood test. In medical terms, it is an in-vitro diagnostic test, which is essentially a test done on samples such as blood taken from human body.
The test requires withdrawing a low volume (10ml) of blood from the patient. The blood will be withdrawn by a trained phlebotomist or a nurse.
We recommend testing once every 3 months to understand the real-time status of the cancer in your body.
For patients currently undergoing therapy, the Oncologist will decide on the timepoint and frequency of testing.
There are no special preparations required for getting tested. You do not need to fast or avoid any food before the test.
There are no special preparations required for getting tested. You do not need to stop any medicine before the blood test.
If no cancer cells were detected by the OncoDiscover® CTC Test, it only means that at present cancer cells are not present in your bloodstream. A cancer cell which may be dormant currently may express itself later. It is essential to continuously monitor the status of cancer.
Only an Oncologist is qualified to decide on the course of action based on the test results. We shall not offer any advice or consultation on cancer therapy.
This test is a real time test of cancer status in the body. This test does not determine the future status of cancer.
Fighting cancer.
One cell at a time.
One in a billion cells.
Even a single tumor cell can cause cancer relapse and can lead to metastasis (spread of cancer). OncoDiscover® CTC detects, with pinpoint accuracy, those pesky cells whose presence, even a single one of them, leads to the spread of cancer even after the patient’s treatment has been completed and the patient seems to have recovered.
Cost-effective
The OncoDiscover® CTC has been developed with a goal of making it affordable and accessible to everyone who is in need of it. It is 50% cheaper than any other test to diagnose cancer cells.
Time Saving
At OncoDiscover® laboratory the diagnostic test are run on the blood samples of the patients. Typically a complete run cycle is completed within a weeks time followed by analysis by scientific experts.
Accurate
The OncoDiscover® CTC test can identify pesky tumor cells amongst billions of cells in the blood samples from the patients. It is as accuarate as counting one in a billion cells from the blood sample.
Safe
The OncoDiscover® CTC test is absolutely safe. Only patients blood sample is collected and subject to the diagnostic runs. Patients don’t need to through any other tests including that involving radiations.
Convenient
The OncoDiscover® CTC is a simple blood test. Just book the Test online or through a phone call. Our registered phlebotomists can collect the blood samples from patient’s home.
Pain-free
The patient doesn’t have to go through any medical procedure or go through any tissue biopsy. All that it needs is patients blood samples - ensuring its physically and emotionally pain-free for the patient.
Early detection is half the battle won.
Book a Test
Simply book a Test online or over a phone call and schedule a visit by our registered phlebotomists.
Sample Collection
Upon booking the Test, one of our registered phlebotomists shall visit and collect 10 ml of patient’s blood sample.
Receive Report
A set of diagnostics will be run on the patient’s blood sample and the report shall be provided in 7 working days upon receipt of sample on site.